Additional file 1 of High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients

  • Xuan Yang (Creator)
  • Mohamed Amgad (Creator)
  • Lee Alex Donald Cooper (Creator)
  • Yuhong Du (Contributor)
  • Haian Fu (Contributor)
  • Andrei A. Ivanov (Creator)
  • Fu Haian (Contributor)
  • Andrey A. Ivanov (Creator)

Dataset

Description

Additional file 1: Table S1. Differential gene expression analysis. Table S2. Modules of co-expressed genes identified with the Weighted Gene Co-expression Network Analysis (WGCNA). Table S3. Gene module pathway overrepresentation analysis. Table S4. Breast cancer patient survival analysis for genes upregulated in African American patients as compared to White patients. Table S5. Univariate COX regression survival analysis for TNBC Balck/African American patients. Table S6. Multivariate COX regression survival analysis for TNBC Balck/African American patients. Table S7. Analysis of genomic alterations of MKK3. Table S8. Genomic status of MKK3 (MAP2K3 gene) and p38 (MAPK14 gene) in BRCA patients and associated clinical data. Table S9. Correlation between MKK3 overexpression and breast cancer patient survival. Table S10. MKK3 gene set enrichment analysis using the MSigDB cancer Hallmark sets. Table S11. MKK3 gene set enrichment analysis for MYC-regulated gene sets. Table S12. Pathway overrepresentation analysis for MYC-dependent genes enriched in TNBC patients with overexpressed MKK3.
Date made available2020
Publisherfigshare

Cite this